Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06788977 · ClinicalTrials.gov registry record
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
A clinical trial of Depression and Anxiety, sponsored by Cefaly Technology.
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT06788977 is a study of Depression and Anxiety that is actively recruiting participants, run by Cefaly Technology. The registered enrollment target is 550 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06788977, a study of Depression and Anxiety, is actively recruiting participants, sponsored by Cefaly Technology.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry. The main question it aims to answer is: Is external trigeminal nerve stimulation a safe and effective option for migraine treatment during and after pregnancy? There are no required changes in migraine treatment to participate in this registry. Participants may or may not use external trigeminal nerve stimulation or any other treatment they currently use and may still participate in the registry. There are no clinic or research visits, as the registry is entirely online. Participants will be asked to complete up to six 15- 20-minute surveys over a time period of up to 12 months.
Conditions Studied
Interventions
- DEVICE external Trigeminal Nerve Stimulation
Study Locations (1)
Connecticut
- https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true - Darien
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2024-11-25 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06788977
The ClinicalTrials.gov registry entry for NCT06788977 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 679 other Depression trials with a reported enrollment target (30% lower). The listed sponsor is Cefaly Technology, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which external Trigeminal Nerve Stimulation is the first listed.
NCT06788977 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06788977 about?
NCT06788977 is a clinical study titled "External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy". This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry. ...
What is the current status of trial NCT06788977?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2024-11-25. Estimated completion is 2030-12.
What conditions does trial NCT06788977 study?
This clinical trial studies the following conditions: Depression, Anxiety, Pregnancy, Migraine, Headache.
What interventions are being tested in trial NCT06788977?
The interventions under investigation include: external Trigeminal Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06788977?
This trial is sponsored by Cefaly Technology, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06788977 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.